Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variables (Q2919476)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variables |
scientific article; zbMATH DE number 6089956
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variables |
scientific article; zbMATH DE number 6089956 |
Statements
Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variables (English)
0 references
2 October 2012
0 references
biserial correlation
0 references
intersection-union test
0 references
latent variable
0 references
multiplicity
0 references
multivariate normal
0 references
0 references
0.7466866970062256
0 references
0.7133469581604004
0 references
0.6830849051475525
0 references
0.6716049909591675
0 references
